<VariationArchive VariationID="1073072" VariationName="NC_000007.13:g.(?_94228081)_(94232770_?)del" VariationType="Deletion" Accession="VCV001073072" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2021-05-10" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1057305" VariationID="1073072">
      <GeneList>
        <Gene Symbol="SGCE" FullName="sarcoglycan epsilon" GeneID="8910" HGNC_ID="HGNC:10808" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="94584980" stop="94656133" display_start="94584980" display_stop="94656133" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="94214535" stop="94285520" display_start="94214535" display_stop="94285520" Strand="-" />
          </Location>
          <OMIM>604149</OMIM>
          <Haploinsufficiency last_evaluated="2021-11-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SGCE">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-11-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SGCE">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000007.13:g.(?_94228081)_(94232770_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" innerStart="94228081" innerStop="94232770" display_start="94228081" display_stop="94232770" variantLength="4690" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(?_94228081)_(94232770_?)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(?_94228081)_(94232770_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.13:g.(?_94228081)_(94232770_?)del AND Myoclonic dystonia 11" Accession="RCV001385957" Version="8">
        <ClassifiedConditionList TraitSetID="1614">
          <ClassifiedCondition DB="MedGen" ID="C1834570">Myoclonic dystonia 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-05-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-05-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19066193</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1614" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3138" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myoclonic dystonia 11</ElementValue>
                <XRef ID="MONDO:0008044" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, alcohol responsive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary essential myoclonus</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonus-Dystonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYT-SGCE</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonic dystonia</ElementValue>
                <XRef ID="Dystonia+11/2408" DB="Genetic Alliance" />
                <XRef ID="439732004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 11</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DYT11</ElementValue>
                <XRef Type="MIM" ID="159900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18616" />
                <XRef ID="18616" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">SGCE myoclonus-dystonia (SGCE-M-D) is a movement disorder characterized by a combination of rapid, brief muscle contractions (myoclonus) and/or sustained twisting and repetitive movements that result in abnormal postures (dystonia). The myoclonic jerks typical of SGCE-M-D most often affect the neck, trunk, and upper limbs with less common involvement of the legs. Approximately 50% of affected individuals have additional focal or segmental dystonia, presenting as cervical dystonia and/or writer's cramp. Non-motor features may include alcohol abuse, obsessive-compulsive disorder (OCD), and anxiety disorders. Symptom onset is usually in the first decade of life and almost always by age 20 years, but ranges from age six months to 80 years. Most affected adults report a dramatic reduction in myoclonus in response to alcohol ingestion. SGCE-M-D is compatible with an active life of normal span.</Attribute>
                <XRef ID="NBK1414" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301587</ID>
                <ID Source="BookShelf">NBK1414</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <XRef ID="36899" DB="Orphanet" />
              <XRef ID="C1834570" DB="MedGen" />
              <XRef ID="MONDO:0008044" DB="MONDO" />
              <XRef Type="MIM" ID="159900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3111640" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_003919.2_7_Deletion (exons 6-9)|MedGen:C1834570" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001585994" DateUpdated="2024-06-09" DateCreated="2021-05-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19066193</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Gross deletions of SGCE are known to be pathogenic. ¬†A similar copy number change has been reported in an individual with myclonus dystonia (PMID: 19066193). This variant is a gross deletion of the genomic region encompassing exons 6-9 of the SGCE gene. This leads to an in-frame deletion, preserving the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SGCE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(?_94228081)_(94232770_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1834570" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3111640" TraitType="Disease" MappingType="XRef" MappingValue="C1834570" MappingRef="MedGen">
        <MedGen CUI="C1834570" Name="Myoclonic dystonia 11" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

